Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00462891 · ClinicalTrials.gov registry record · NA
A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 6,730
- Enrollment target
NCT00462891: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00462891 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 6,730 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (380% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00462891, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,730 participants
- Enrollment target
Study Summary
RATIONALE: Screening may help doctors find breast cancer cells early and plan better treatment for breast cancer. The Mammography FastTrack program may be effective in increasing the number of patients who undergo mammography. PURPOSE: This randomized clinical trial is studying the use of a Mammography FastTrack program to increase the number of women who undergo mammography.
Primary Outcome
Proportion of overdue patients completing mammography screening in intervention and control groups over the 1-year study.
Interventions
- OTHER IT System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,730 participants |
| Start Date | 2007-03 |
| Phase | NA |
What the finished NCT00462891 record still lists
NCT00462891 is an interventional study that assigns participants to a tested intervention. Its 6,730 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (380% higher).
The record links to 0 conditions, and to 1 intervention - of which IT System is the first listed.
NCT00462891 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00462891 about?
NCT00462891 is a clinical study titled "A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening". RATIONALE: Screening may help doctors find breast cancer cells early and plan better treatment for breast cancer. The Mammography FastTrack program may be effective in increasing the number of patients who undergo mammography. PURPOSE: This randomized clinical trial is studying the use of a Mammogr...
What is the current status of trial NCT00462891?
This trial is currently completed. It is a NA study. The enrollment target is 6,730 participants. The study started on 2007-03.
What interventions are being tested in trial NCT00462891?
The interventions under investigation include: IT System (OTHER).
Who is sponsoring clinical trial NCT00462891?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00462891's enrollment target sits among peer trials
6,730 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05121324 · 6,700 participants · Phase 3
Pediatric Dose Optimization for Seizures in Emergency Medical Services
- NCT03887715 · 6,800 participants · NA
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- NCT06234384 · 6,833 participants
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
- NCT06272045 · 6,618 participants · NA
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia